Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
RIPC-SAH
Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage
1 other identifier
interventional
20
1 country
1
Brief Summary
Rupture of brain aneurysms is a common cause of death and disability, accounting for as many as 10% of stroke cases in the United States. While much of the resulting injury to the nervous system is caused by the initial bleeding from the aneurysm, many of these patients develop cerebral vasospasm, pathological constriction of the blood vessels supplying the brain, several days following hemorrhage. As many as a third of patients can suffer a resulting neurological deficit and stroke, presumably caused by the decreased blood flow to the brain (ischemia). This delayed brain injury accounts for a significant percentage of poor outcomes following aneurysm rupture. Studies have shown that remote ischemia to many organs can precondition other tissues (including the brain) to be more tolerant to decreases in blood flow. This "remote ischemic preconditioning" has the promise of protecting the brain from ischemic injury. Whereas in other forms of stroke the onset of ischemia cannot be predicted in the general population, following aneurysm rupture the investigators know which patients are likely to develop vasospasm and when. Therefore, ischemic preconditioning following aneurysm rupture may help prevent some of the ischemic injury caused by vasospasm. Remote ischemic preconditioning by transient limb ischemia (produced by inflation of a blood pressure cuff on the arm or leg) has been shown to minimize injury to other organs, most notably the heart. Remote ischemic preconditioning of the brain following aneurysm rupture has not yet been investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Apr 2010
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 25, 2010
CompletedFirst Posted
Study publicly available on registry
July 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedNovember 28, 2016
November 1, 2016
3.8 years
June 25, 2010
November 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Occurrence of neurological events, or vasospasm
At days 3
Occurrence of neurological events, or vasospasm
At day 7
Occurrence of neurological events, or vasospasm
At day 15
Occurrence of neurological events, or vasospasm
At day 30
Secondary Outcomes (3)
Transcranial Doppler Measurements and metabolic assessment
At days 3
Transcranial Doppler Measurements and metabolic assessment
At day 7
Transcranial Doppler Measurements and metabolic assessment
At day 15
Study Arms (1)
Remote Ischemic Preconditioning
EXPERIMENTALPatients with aneurysmal subarachnoid hemorrhage, after aneurysm treatment, will be given prophylactic remote ischemic preconditioning by transient lower limb ischemia.
Interventions
Transient lower limb ischemia will be induced by inflation of a blood pressure cuff on the thigh. Four five minute cycles of ischemia will be performed, each followed by five minutes of reperfusion with the cuff down. This procedure will be performed in four rounds, typically on post-hemorrhage days 2, 3, 6 and 9.
Eligibility Criteria
You may qualify if:
- Diagnosis of recent aneurysmal subarachnoid hemorrhage.
- Definitive treatment of the aneurysm by surgical clipping or endovascular coiling has been completed.
You may not qualify if:
- Patients with unprotected (untreated) cerebral aneurysms.
- Patients with a known history of lower limb vascular disease, lower limb vascular bypass surgery and/or peripheral neuropathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Ronald Reagan Medical Center
Los Angeles, California, 90095, United States
Related Publications (1)
Gonzalez NR, Connolly M, Dusick JR, Bhakta H, Vespa P. Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery. 2014 Nov;75(5):590-8; discussion 598. doi: 10.1227/NEU.0000000000000514.
PMID: 25072112RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nestor R Gonzalez, MD
University of California, Los Angeles David Geffen School of Medicine, Departments of Neurosurgery and Radiology
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2010
First Posted
July 8, 2010
Study Start
April 1, 2010
Primary Completion
January 1, 2014
Study Completion
July 1, 2014
Last Updated
November 28, 2016
Record last verified: 2016-11